MIDDLEKAUFF W BRADFORD
Insider CIK 1214501 · EDGE Senior VP, GC and Secretary · IMVT General Counsel · TRML CBO, GC and Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRML Tourmaline Bio, Inc. | D To issuer deriv | 2025-10-28 | 2025-10-28 | 58,000 | — | $0 | 0 | SEC↗ |
| TRML Tourmaline Bio, Inc. | D To issuer deriv | 2025-10-28 | 2025-10-28 | 46,774 | — | $0 | 0 | SEC↗ |
| TRML Tourmaline Bio, Inc. | D To issuer deriv | 2025-10-28 | 2025-10-28 | 124,991 | — | $0 | 0 | SEC↗ |
| TRML Tourmaline Bio, Inc. | D To issuer | 2025-10-28 | 2025-10-28 | 8,213 | — | $0 | 0 | SEC↗ |
| TRML Tourmaline Bio, Inc. | U Tender | 2025-10-28 | 2025-10-28 | 60,988 | — | $0 | 8,213 | SEC↗ |
| TRML Tourmaline Bio, Inc. | A Award deriv | 2025-01-27 | 2025-01-29 | 58,000 | — | $0 | 58,000 | SEC↗ |
| TRML Tourmaline Bio, Inc. | A Award deriv | 2023-10-23 | 2023-10-23 | 46,774 | — | $0 | 46,774 | SEC↗ |
| TRML Tourmaline Bio, Inc. | A Award deriv | 2023-10-19 | 2023-10-23 | 124,991 | — | $0 | 124,991 | SEC↗ |
| TRML Tourmaline Bio, Inc. | A Award | 2023-10-19 | 2023-10-23 | 69,201 | — | $0 | 69,201 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2020-05-15 | 2020-05-18 | 142,600 | — | $0 | 142,600 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 211,277 | — | $0 | 211,277 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 489 | — | $0 | 489 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise deriv | 2019-03-15 | 2019-03-18 | 49,766 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise | 2019-03-15 | 2019-03-18 | 49,766 | — | $0 | 59,766 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-08-14 | 2018-08-15 | 49,766 | — | $0 | 49,766 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-20 | 99,534 | — | $0 | 99,534 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-03-01 | 2018-03-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2017-03-13 | 2017-03-15 | 52,500 | $8.86 | $465.1K | 52,500 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-08-08 | 2016-08-09 | 143 | $9.43 | $1.3K | 10,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-08-05 | 2016-08-09 | 9,857 | $9.48 | $93.4K | 9,857 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2016-02-16 | 2016-02-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2015-11-16 | 2015-11-18 | 80,000 | — | $0 | 80,000 | SEC↗ |